Human Molecular Genetics
Group leader
A/Professor Vincent Harley
Short CV [pdf]
This group is investigating the role of three human genes involved in the formation and function of the testis (SRY and SOX9), bone (SOX9) and the pancreas (SOX13). Disruption of the normal function of these genes cause disease. Therefore, analysing them could potentially lead to the development of new treatments for the diseases that they are involved in.
Research Projects available:
1. The role of SRY in the brain
Supervisors: Dr Joohyung Lee and Associate Professor Vincent Harley
Contact: vincent.harley@princehenrys.org, joohyung.lee@princehenrys.org
Parkinson’s Disease (PD) causes involuntary movement or tremors. Interestingly, PD occurs 1.5 times more often in men than in women. We think this could be due in part to the sex chromosome differences between males (XY) and females (XX). We have evidence that SRY, the “male only” gene on the Y chromosome responsible for the presence of testicles, also makes SRY protein in men’s brains. When SRY is removed from rats’ brains, the male rats develop movement problems reminiscent of those seen in PD which are reversed when SRY levels are restored. The movement problems in PD and in these rats occur due to a reduction of an enzyme called TH which is essential for dopamine production. We have discovered that SRY can regulate TH in human dopamine-producing cells. This project aims to understand at the molecular level how SRY controls TH. Secondly SRY protein levels will be investigated in men with PD to test the hypothesis that lower TH levels are a consequence of lower SRY levels in PD men. This would implicate SRY as a contributing factor in increased susceptibility of men to PD.
2. The Sox9 knockout mouse: A mouse model for Disorders of Sexual Development
Supervisors: Dr Stefan Bagheri-Fam and Associate Professor Vincent Harley
Contact: stefan.bagheri-fam@princehenrys.org, vincent.harley@princehenrys.org
In mammals, sex is determined in the bipotential foetal gonad by a balanced network of protein interactions. If this network is altered Disorders of Sexual Development (DSD, formerly known as intersex) can arise. Human mutations in SOX9 cause male-to-female sex reversal in XY individuals. Using the Cre-loxP recombination technology we have conditionally inactivated Sox9 in the gonad in mice. This has allowed us to follow the fate of sex reversed Sox9 -/-XY gonads in vivo throughout gonadal formation during embryogenesis. These gonads will be analysed by immunohistochemistry, in situ hybridisation and RT-PCR to investigate the molecular consequences of the loss of Sox9. This project will also include a microarray analysis of the XY Sox9 knockout gonad targeted at the identification of genes involved in testis formation.
3. The role of SOX9 in craniofacial development
Supervisors: Dr Stefan Bagheri-Fam and Associate Professor Vincent Harley
Contact: stefan.bagheri-fam@princehenrys.org, vincent.harley@princehenrys.org
Abnormalities in the bones of the face and skull are present in 30% of children with birth defects, yet the underlying causes are largely unknown. These anomalies begin very early in the first trimester when the cranial neural crest is forming. A candidate gene is SOX9 in which mutations lead to craniofacial malformations including Pierre-Robin sequence (small lower jaw, cleft palate and tongue defects). We developed a mouse model by inactivating the Sox9 gene in mice prior to cranial neural crest formation. These mice have fewer cranial neural crest cells leading to craniofacial defects ranging from cleft palate to severe facial clefting reflecting the broad range of human craniofacial defects. This project aims to analyse Sox9-deficient mice step by step through embryogenesis to define the morphological events leading to facial anomalies. This will provide new insights into why development does not proceed normally in patients with craniofacial anomalies.
4. Functional characterisation of the chromatin-remodelling protein, ATRX
Supervisors: Dr Anthony Argentaro and Associate Professor Vincent Harley
Contact: vincent.harley@princehenrys.org, anthony.argentaro@princehenrys.org
The ATR-X syndrome is a severe developmental disorder resulting in a mental retardation, characteristic facial and skeletal abnormalities, alpha thalassaemia and urogenital abnormalities. The ATRX protein comprises two highly conserved domains; a N-terminal PHD-like domain and a C-terminal helicase-like domain which shares homology to the SNF2 family of chromatin remodelling proteins. The functional importance of these domains is highlighted by the fact that the majority of the clinical mutations are located within these domains.
Mutations which arise in a third domain located in the extreme C-terminus almost always results in complete XY sex reversal in patients suggesting that this region plays an important role in urogenital development.
Two project areas are on offer in understanding the role of ATRX in urogenital development 1) identifying and characterising proteins which interact with the C-terminal domain of the ATRX protein and 2) characterisation of mice lacking ATRX.
5. Functional analysis of miRNAs in the developing testis
Supervisors: Dr Stefan Bagheri-Fam and Associate Professor Vincent Harley
Contact: stefan.bagheri-fam@princehenrys.org, vincent.harley@princehenrys.org
MicroRNAs (miRNAs) are critical regulators of transcriptional and post-transcriptional gene silencing, which are involved in multiple developmental processes in many organisms. Over 100 miRNAs have been found in the mouse testis; however the function of these miRNA during testicular development is unclear. This project aims to analyse the role of miRNA biogenesis in testis development by using conditional Dicer-knockout mice in which Dicergene will be deleted specifically in the testis.
Human Molecular Genetics laboratory in the media
Graeme O'Neill, Australian Life Scientist, January/February 2007, "The genes that maketh the man", Australian Biotechnology News
The Sunday Age 19 March 2006, "Bright Minds, Big City"
This article describes research in which Vincent Harley and his team are investigating the connecting between the SRY protein and Parkinson's disease. Their results obtained from mouse studies promise the possibility of treating Parkinson's disease using drugs that control the levels of SRY in the brain.
New Scientist. Oct 27, 2008. Male-to-female transsexualism gene found
Holden, C. "Gender and the Brain" Science 322: 831 (November 7, 2008)
Australian Life Scientist article "Polymorphism link in transsexualism" (6 February 2009)
Holden, C. "Thinking ‘Bout Sex" ScienceNOW Daily News. (February 21,2006)
Dennis, C. "Sex on the brain" News@nature.com (February 21, 2006)
Four Corners program: "The Gender Puzzle" ABC 25 July 2005
Dennis, C. The most important sexual organ. Nature: News Feature 6973: 390-392 (2004).
News of the Week, Cell Biology "In Sex reversal: Protein deterred by Nuclear Barrier", Science 19 Dec 2003, Vol 302:2050
© Prince Henry's Institute of Medical Research ABN 48 132 025 024 Disclaimer | Links to other sites
|